Oaktree Acquisition Corp. III Life Sciences (OACC) stock
OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026
$10.70+0.00 (0.00%)
Close on Nov 13, 2026Market cap $263.04MP/E –Yield –
Oaktree Acquisition Corp. III Life Sciences EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
No eps figures for Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?